Is IVIXF or NOBL a better dividend investment in 2026?

IVIXF currently yields 5420.05% with a 5% 5-year dividend growth rate. NOBL yields 2.14% with 5% growth. The better choice depends on your goal: IVIXF offers higher current income.

What is the dividend yield difference between IVIXF and NOBL?

IVIXF has a forward dividend yield of 5420.05% ($2.00/share annually). NOBL yields 2.14% ($2.27/share annually). The yield gap is 5417.91 percentage points.

Home › Compare › IVIXF vs NOBL

IVIXF vs NOBL: Dividend Comparison 2026

IVIXF yields 5420.05% · NOBL yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IVIXF wins by $136326195118802.22M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IVIXF

● Live price

5420.05%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$136326195118802.23M

Annual income

$131,551,666,493,773,860,000.00

Full IVIXF calculator →

NOBL

● Live price

2.14%

Share price

$106.01

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.8K

Annual income

$246.19

Full NOBL calculator →

Portfolio growth — IVIXF vs NOBL

📍 IVIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IVIXF	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IVIXF + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IVIXF pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IVIXF

Annual income on $10K today (after 15% tax)

$460,704.61/yr

After 10yr DRIP, annual income (after tax)

$111,818,916,519,707,770,000.00/yr

NOBL

Annual income on $10K today (after 15% tax)

$182.19/yr

After 10yr DRIP, annual income (after tax)

$209.26/yr

At 15% tax rate, IVIXF beats the other by $111,818,916,519,707,770,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IVIXF + NOBL for your $10,000?

IVIXF: 50%NOBL: 50%

100% NOBL50/50100% IVIXF

Portfolio after 10yr

$68163097559401.13M

Annual income

$65,775,833,246,886,930,000.00/yr

Blended yield

96.50%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IVIXF buys

NOBL buys

No recent congressional trades found for IVIXF or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIVIXFNOBL

Forward yield	5420.05% ✓	2.14%
Annual dividend / share	$2.00	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$136326195118802.23M ✓	$22.8K
Annual income after 10y	$131,551,666,493,773,860,000.00 ✓	$246.19
Total dividends collected	$136003983287005.17M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: IVIXF vs NOBL ($10,000, DRIP)

Year	IVIXF Portfolio	IVIXF Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$552,705	$542,005.42	$10,914	$214.34	+$541.8K → IVIXF
2	$28,588,529	$27,997,133.96	$11,897	$218.63	+$28.58M → IVIXF
3	$1,383,995,048	$1,353,405,322.61	$12,952	$222.72	+$1383.98M → IVIXF
4	$62,714,057,337	$61,233,182,635.19	$14,086	$226.62	+$62714.04M → IVIXF
5	$2,660,288,543,813	$2,593,184,502,462.66	$15,302	$230.33	+$2660288.53M → IVIXF
6	$105,651,330,702,723	$102,804,821,960,842.73	$16,607	$233.85	+$105651330.69M → IVIXF
7	$3,928,761,972,612,137	$3,815,715,048,760,222.50	$18,007	$237.18	+$3928761972.59M → IVIXF
8	$136,812,745,737,264,320	$132,608,970,426,569,340.00	$19,508	$240.35	+$136812745737.24M → IVIXF
9	$4,462,176,285,073,260,500	$4,315,786,647,134,387,700.00	$21,116	$243.35	+$4462176285073.24M → IVIXF
10	$136,326,195,118,802,240,000	$131,551,666,493,773,860,000.00	$22,841	$246.19	+$136326195118802.22M → IVIXF

IVIXF vs NOBL: Complete Analysis 2026

IVIXF — Stock

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

Full IVIXF Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this IVIXF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IVIXF vs SCHD IVIXF vs JEPI IVIXF vs O IVIXF vs KO IVIXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.